The Histone‐Deacetylase‐Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase‐13 Activity
暂无分享,去创建一个
[1] B. Hille,et al. Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support , 2016, PloS one.
[2] J. Ahn,et al. Solute Carrier Organic Anion Transporter Family Member 4A1 (SLCO4A1) in Colorectal Cancer , 2016 .
[3] S. Harris,et al. Establishment of Immortalized Mouse Bmp2 Knock‐Out Dental Papilla Mesenchymal Cells Necessary for Study of Odontoblastic Differentiation and Odontogenesis , 2015, Journal of cellular physiology.
[4] M. McBurney,et al. Sirtuin 1 Is a Negative Regulator of Parathyroid Hormone Stimulation of Matrix Metalloproteinase 13 Expression in Osteoblastic Cells , 2015, The Journal of Biological Chemistry.
[5] J. Granjeiro,et al. Bone tissue remodeling and development: focus on matrix metalloproteinase functions. , 2014, Archives of biochemistry and biophysics.
[6] N. Mahmud,et al. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] L. Altucci,et al. Histone Deacetylase Inhibition with Valproic Acid Downregulates Osteocalcin Gene Expression in Human Dental Pulp Stem Cells and Osteoblasts: Evidence for HDAC2 Involvement , 2014, Stem cells.
[8] Junlin Qi,et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy , 2013, Disease Models & Mechanisms.
[9] Lucas R. Smith,et al. Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration. , 2013, American journal of physiology. Cell physiology.
[10] Y. Li,et al. Histone Deacetylase Inhibition Promotes Osteoblast Maturation by Altering the Histone H4 Epigenome and Reduces Akt Phosphorylation* , 2013, The Journal of Biological Chemistry.
[11] Yan Wang,et al. MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. , 2013, Toxicology letters.
[12] Benjamin E. L. Lauffer,et al. Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability , 2013, The Journal of Biological Chemistry.
[13] M. Capogrossi,et al. Enhancement of lysine acetylation accelerates wound repair , 2013, Communicative & integrative biology.
[14] P. Huang,et al. CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells. , 2013, International endodontic journal.
[15] A. Kolokythas,et al. Epigenetic marks define the lineage and differentiation potential of two distinct neural crest-derived intermediate odontogenic progenitor populations. , 2013, Stem cells and development.
[16] H. Duncan,et al. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells. , 2013, Experimental cell research.
[17] B. Turner,et al. The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing , 2013, Epigenetics & Chromatin.
[18] P. Croucher,et al. Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo , 2013, Acta Pharmacologica Sinica.
[19] C. Cellai,et al. Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells , 2013, PloS one.
[20] P. Choung,et al. HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. , 2013, Tissue engineering. Part A.
[21] E. Patsouris,et al. Current evidence for histone deacetylase inhibitors in pancreatic cancer. , 2013, World journal of gastroenterology.
[22] R. Raghow,et al. Pan-histone deacetylase inhibitors regulate signaling pathways involved in proliferative and pro-inflammatory mechanisms in H9c2 cells , 2012, BMC Genomics.
[23] R. Shelton,et al. Recruitment of dental pulp cells by dentine and pulp extracellular matrix components. , 2012, Experimental cell research.
[24] H. Kiyonari,et al. Osterix Regulates Calcification and Degradation of Chondrogenic Matrices through Matrix Metalloproteinase 13 (MMP13) Expression in Association with Transcription Factor Runx2 during Endochondral Ossification* , 2012, The Journal of Biological Chemistry.
[25] C. Chen,et al. HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy , 2012, Clinical Cancer Research.
[26] H. Ryoo,et al. Suberoylanilide Hydroxamic Acid Enhances Odontoblast Differentiation , 2012, Journal of dental research.
[27] H. Duncan,et al. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. , 2012, Journal of endodontics.
[28] W. Bloch,et al. Histone deacetylases 2 and 9 are coexpressed and nuclear localized in human molar odontoblasts in vivo , 2012, Histochemistry and Cell Biology.
[29] Chris T. A. Evelo,et al. WikiPathways: building research communities on biological pathways , 2011, Nucleic Acids Res..
[30] H. Duncan,et al. HDACi , 2011, Journal of dental research.
[31] G. Stein,et al. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts. , 2011, Bone.
[32] Jennifer J Westendorf,et al. Histone deacetylases in skeletal development and bone mass maintenance. , 2011, Gene.
[33] Sarah G. Bailey,et al. Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases. , 2010, Current drug targets.
[34] P. Marks. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. , 2010, Biochimica et biophysica acta.
[35] Minnkyong Lee,et al. Parathyroid Hormone Activation of Matrix Metalloproteinase-13 Transcription Requires the Histone Acetyltransferase Activity of p300 and PCAF and p300-dependent Acetylation of PCAF* , 2010, The Journal of Biological Chemistry.
[36] F. Flamigni,et al. Matrix metalloproteinase 13 loss associated with impaired extracellular matrix remodeling disrupts chondrocyte differentiation by concerted effects on multiple regulatory factors. , 2010, Arthritis and rheumatism.
[37] N. Hukriede,et al. Inhibition of histone deacetylase expands the renal progenitor cell population. , 2010, Journal of the American Society of Nephrology : JASN.
[38] D. Musson,et al. Adrenomedullin is expressed during rodent dental tissue development and promotes cell growth and mineralization , 2010, Biology of the cell.
[39] E. Olson,et al. HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This Repression* , 2010, The Journal of Biological Chemistry.
[40] Susan Groshen,et al. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines , 2009, BMC Medical Genomics.
[41] Allan Kuchinsky,et al. Alternative Splicing in the Differentiation of Human Embryonic Stem Cells into Cardiac Precursors , 2009, PLoS Comput. Biol..
[42] C. Bagni,et al. Acetylation of RTN-1C regulates the induction of ER stress by the inhibition of HDAC activity in neuroectodermal tumors , 2009, Oncogene.
[43] P. Cooper,et al. Phenotype and behaviour of dental pulp cells during expansion culture. , 2009, Archives of oral biology.
[44] I. Fichtner,et al. Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models. , 2009, International journal of oncology.
[45] Joan W. Miller,et al. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications. , 2009, Investigative ophthalmology & visual science.
[46] T. Nakajima,et al. MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. , 2009, The American journal of pathology.
[47] J. Eun,et al. Systemic cell-cycle suppression by Apicidin, a histone deacetylase inhibitor, in MDA-MB-435 cells. , 2009, International journal of molecular medicine.
[48] W-S Xu,et al. Histone deacetylase inhibitors: Potential in cancer therapy , 2009, Journal of cellular biochemistry.
[49] L. Zolla,et al. A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. , 2008, Biochimica et biophysica acta.
[50] Chris T. A. Evelo,et al. Presenting and exploring biological pathways with PathVisio , 2008, BMC Bioinformatics.
[51] J. Keen,et al. Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR , 2008, Breast Cancer Research and Treatment.
[52] E. Gagari,et al. Expression of MMP-13 (collagenase-3) in long-term cultures of human dental pulp cells. , 2008, Archives of oral biology.
[53] S. Krane,et al. Matrix metalloproteinases and bone. , 2008, Bone.
[54] Robert W. Li,et al. Butyrate Induced Cell Cycle Arrest in Bovine Cells through Targeting Gene Expression Relevant to DNA Replication Apparatus , 2008, Gene regulation and systems biology.
[55] P. Cooper,et al. Dental regeneration and materials—a partnership , 2008, Clinical Oral Investigations.
[56] P. Finn,et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. , 2008, The Biochemical journal.
[57] J. S. Rao,et al. Inhibition of Histone Deacetylase Activity Promotes Invasion of Human Cancer Cells through Activation of Urokinase Plasminogen Activator* , 2007, Journal of Biological Chemistry.
[58] Z. Werb,et al. Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration , 2007, PloS one.
[59] J. Westendorf,et al. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors , 2007, BMC Genomics.
[60] S. Reppe,et al. Levetiracetam, Phenytoin, and Valproate Act Differently on Rat Bone Mass, Structure, and Metabolism , 2007, Epilepsia.
[61] L. Grover,et al. Dissolution of bio-active dentine matrix components by mineral trioxide aggregate. , 2007, Journal of dentistry.
[62] F. García-Godoy,et al. Regenerative endodontics: a review of current status and a call for action. , 2007, Journal of endodontics.
[63] C. Hansch,et al. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. , 2007, Bioorganic & medicinal chemistry.
[64] M. Szyf,et al. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. , 2007, Carcinogenesis.
[65] T. Nagashima,et al. Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. , 2007, Endocrinology.
[66] H. Quentmeier,et al. Epigenetic regulation of brain expressed X-linked-2, a marker for acute myeloid leukemia with mixed lineage leukemia rearrangements , 2007, Leukemia.
[67] Leo Tjäderhane,et al. The role of matrix metalloproteinases in the oral environment , 2007, Acta odontologica Scandinavica.
[68] N. Belyaev,et al. BRG1 Chromatin Remodeling Activity Is Required for Efficient Chromatin Binding by Repressor Element 1-silencing Transcription Factor (REST) and Facilitates REST-mediated Repression* , 2006, Journal of Biological Chemistry.
[69] L. Guarente,et al. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.
[70] C. V. van Blitterswijk,et al. Inhibition of histone acetylation as a tool in bone tissue engineering. , 2006, Tissue engineering.
[71] Jessica E. Bolden,et al. Anticancer activities of histone deacetylase inhibitors , 2006, Nature Reviews Drug Discovery.
[72] Timothy C Ryken,et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. , 2006, Cancer research.
[73] J. Westendorf,et al. Histone Deacetylase Inhibitors Promote Osteoblast Maturation , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[74] P. Marks,et al. Histone deacetylase inhibitors: discovery and development as anticancer agents , 2005, Expert opinion on investigational drugs.
[75] Hyunjin Cho,et al. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors , 2005, Journal of cellular biochemistry.
[76] Ding‐Shinn Chen,et al. Epigenetic activation of α4, β2 and β6 integrins involved in cell migration in trichostatin A-treated Hep3B cells , 2005 .
[77] T. Yamano,et al. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. , 2005, Cancer research.
[78] Mahboob Rahman,et al. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[79] H. Yoo,et al. Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. , 2004, Biological & pharmaceutical bulletin.
[80] A. Scarpa,et al. Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. , 2004, Biochimica et biophysica acta.
[81] R. Ala-aho,et al. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo , 2004, Oncogene.
[82] D. Prockop,et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. , 2004, Analytical biochemistry.
[83] Ivan V. Gregoretti,et al. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. , 2004, Journal of molecular biology.
[84] Y. Sowa,et al. Trichostatin A activates the osteopontin gene promoter through AP1 site. , 2004, Biochemical and biophysical research communications.
[85] T. Salo,et al. Matrix Metalloproteinase-13 (MMP-13, Collagenase-3) is Highly Expressed in Human Tooth Pulp , 2004, Connective tissue research.
[86] Yang Shi,et al. Ineffectiveness of Histone Deacetylase Inhibitors to Induce Apoptosis Involves the Transcriptional Activation of NF-κB through the Akt Pathway* , 2003, Journal of Biological Chemistry.
[87] Z. Werb,et al. How Proteases Regulate Bone Morphogenesis , 2003, Annals of the New York Academy of Sciences.
[88] F. Dequiedt,et al. Class II histone deacetylases: versatile regulators. , 2003, Trends in genetics : TIG.
[89] T. Salo,et al. Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. , 2003, European journal of oral sciences.
[90] M. King. Preserving the vital pulp in operative dentistry. , 2002, Dental update.
[91] H. V. Van Wart,et al. Proteolysis Involving Matrix Metalloproteinase 13 (Collagenase‐3) Is Required for Chondrocyte Differentiation That Is Associated with Matrix Mineralization , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[92] E. Jansen,et al. Real-time visualization of MMP-13 promoter activity in transgenic mice. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[93] P. Lumley,et al. Preserving the vital pulp in operative dentistry: I. A biological approach. , 2002, Dental update.
[94] Thiennu H. Vu,et al. Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones , 2000, The Journal of cell biology.
[95] Jiahuai Han,et al. Transforming Growth Factor-β Induces Collagenase-3 Expression by Human Gingival Fibroblasts via p38 Mitogen-activated Protein Kinase* , 1999, The Journal of Biological Chemistry.
[96] S. Bloch,et al. Regulation of expression of collagenase‐3 in normal, differentiating rat osteoblasts , 1999, Journal of cellular physiology.
[97] H. Takahashi,et al. Expression of metalloproteinase-13 (Collagenase-3) is induced during fracture healing in mice. , 1999, Bone.
[98] C. Murphy,et al. Effect of Norepinephrine on Proliferation, Migration, and Adhesion of SV‐40 Transformed Human Corneal Epithelial Cells , 1998, Cornea.
[99] M. Iwaku,et al. Immunolocalization of Fibronectin during Reparative Dentinogenesis in Human Teeth after Pulp Capping with Calcium Hydroxide , 1996, Journal of dental research.
[100] U. Schröder. Effects of Calcium Hydroxide-containing Pulp-capping Agents on Pulp Cell Migration, Proliferation, and Differentiation , 1985, Journal of dental research.
[101] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[102] J. Ricker,et al. Vorinostat , 2017, Reactions Weekly.
[103] S. Imazato,et al. Activation of the Wnt/β-catenin pathway and tissue inhibitor of metalloprotease 1 during tertiary dentinogenesis. , 2013, Journal of biochemistry.
[104] M. Swain,et al. Regulation of reactionary dentin formation by odontoblasts in response to polymicrobial invasion of dentin matrix. , 2012, Bone.
[105] M. McGee-Lawrence,et al. Hdac-mediated control of endochondral and intramembranous ossification. , 2011, Critical reviews in eukaryotic gene expression.
[106] R. Kizek,et al. Matrix metalloproteinases. , 2010, Current medicinal chemistry.
[107] P. Atadja,et al. The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance , 2009, Nature Immunology.
[108] J. Heino,et al. Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts. , 2007, The Journal of investigative dermatology.
[109] Ding‐Shinn Chen,et al. Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cells. , 2005, Journal of biomedical science.
[110] Matty P. Weijenberg,et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.
[111] H. Lesot,et al. Reactionary dentinogenesis. , 1995, The International journal of developmental biology.
[112] K. Staines,et al. Identification of novel regulators of osteoblast matrix mineralization by time series transcriptional profiling , 2014, Journal of Bone and Mineral Metabolism.